Santonin-related compound 2 inhibits the nuclear translocation of NF-κB subunit p65 by targeting cysteine 38 in TNF-α-induced NF-κB signaling pathway.
Ryuichi Tamura, Kyoko Morimoto, Seiya Hirano, Liyan Wang, Ming Zhao, Masayoshi Ando, Takao Kataoka
Index: Biosci. Biotechnol. Biochem. 76(12) , 2360-3, (2012)
Full Text: HTML
Abstract
(11S)-2α-Bromo-3-oxoeudesmano-12,6α-lactone, designated santonin-related compound 2 (SRC2), only weakly affected IκBα degradation after tumor necrosis factor-α (TNF-α) stimulation, but strongly blocked the nuclear translocation of nuclear factor κB (NF-κB) subunit p65. Replacement of Cys-38 of p65 with serine abolished the inhibitory effect of SRC2 on this TNF-α-induced nuclear translocation. These results indicate that SRC2 inhibits the nuclear translocation of p65 by targeting Cys-38.
Related Compounds
Related Articles:
2013-01-02
[J. Neurosci. 33(1) , 201-13, (2013)]
2008-04-01
[Pharmacol. Biochem. Behav. 89(2) , 160-70, (2008)]
2013-02-01
[Eur. J. Med. Chem. 60 , 365-75, (2013)]
2006-05-12
[J. Biol. Chem. 281(19) , 13117-25, (2006)]
2006-06-01
[J. Asian Nat. Prod. Res. 8(4) , 317-26, (2006)]